title: Drug companies expected to get more leeway in communicating with patients in Europe.
authors: Anna
authors: A
authors: Sayburn
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence*; D003142:Communication; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D011369:Professional-Patient Relations